DE69115943T2 - Pyrroloazepinderivate - Google Patents

Pyrroloazepinderivate

Info

Publication number
DE69115943T2
DE69115943T2 DE69115943T DE69115943T DE69115943T2 DE 69115943 T2 DE69115943 T2 DE 69115943T2 DE 69115943 T DE69115943 T DE 69115943T DE 69115943 T DE69115943 T DE 69115943T DE 69115943 T2 DE69115943 T2 DE 69115943T2
Authority
DE
Germany
Prior art keywords
group
branched
linear
disclosed
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69115943T
Other languages
English (en)
Other versions
DE69115943D1 (de
Inventor
Akira Mizuno
Hidetsura Cho
Mikiko Hamaguchi
Toshio Tatsuoka
Ishihara Takafumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daichi Suntory Pharma Co Ltd Tokio/tokyo Jp
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of DE69115943D1 publication Critical patent/DE69115943D1/de
Application granted granted Critical
Publication of DE69115943T2 publication Critical patent/DE69115943T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69115943T 1990-02-07 1991-02-06 Pyrroloazepinderivate Expired - Fee Related DE69115943T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2613790 1990-02-07
JP02773991A JP3198117B2 (ja) 1990-02-07 1991-01-30 ピロロアゼピン誘導体

Publications (2)

Publication Number Publication Date
DE69115943D1 DE69115943D1 (de) 1996-02-15
DE69115943T2 true DE69115943T2 (de) 1996-11-14

Family

ID=26363881

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69115943T Expired - Fee Related DE69115943T2 (de) 1990-02-07 1991-02-06 Pyrroloazepinderivate

Country Status (10)

Country Link
US (3) US5206239A (de)
EP (1) EP0441349B1 (de)
JP (1) JP3198117B2 (de)
KR (1) KR100255131B1 (de)
AT (1) ATE132497T1 (de)
AU (1) AU642960B2 (de)
CA (1) CA2035749C (de)
DE (1) DE69115943T2 (de)
DK (1) DK0441349T3 (de)
ES (1) ES2084719T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3198117B2 (ja) * 1990-02-07 2001-08-13 サントリー株式会社 ピロロアゼピン誘導体
JP3242653B2 (ja) * 1991-08-07 2001-12-25 サントリー株式会社 ピロロアゼピン化合物
AU655841B2 (en) * 1991-08-07 1995-01-12 Daiichi Suntory Pharma Co., Ltd Pyrroloazepine derivative
JP3714685B2 (ja) * 1994-05-18 2005-11-09 第一サントリーファーマ株式会社 ハイメニアルディシン及びその誘導体並びにそれらの合成中間体の製造法並びにその合成中間体
US6355659B1 (en) 1994-07-29 2002-03-12 Laboratorios Del Dr. Esteve, S.A. 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
IL121432A (en) 1995-12-01 2000-09-28 Suntory Ltd Pyrrolo [3,2-C]azepine-4-one derivatives and pyrrolo [3,4-C]azepine-4-one derivatives their preparation and pharmaceutical compositions containing them
JPH10251258A (ja) 1997-03-14 1998-09-22 Suntory Ltd ピロロアゼピン系化合物
JPH11193289A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド誘導体
JPH11193290A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物
JP4953826B2 (ja) 2007-01-05 2012-06-13 ソニー株式会社 情報処理装置、表示制御方法、およびプログラム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3563979A (en) * 1966-10-21 1971-02-16 Upjohn Co 1,2,3,4,5,6 - hexahydroazepino(4,3 - b)indoles and 1,2,3,4,5,6-hexahydroazepino(3,2-b)indoles
US3573324A (en) * 1969-02-28 1971-03-30 Upjohn Co 2,3,4,5,10,10a-hexahydroazepino(2,3-b)indoles
US3573323A (en) * 1969-02-28 1971-03-30 Upjohn Co 1,2,3,4,5,10-hexahydroazepino(2,3-b)indoles
JPS62161786A (ja) * 1986-01-08 1987-07-17 Mitsubishi Chem Ind Ltd ピロ−ル化合物
US4729996A (en) * 1986-05-29 1988-03-08 Harbor Branch Oceanographic Institution, Inc. Antitumor compositions and their methods of use
DE3903368A1 (de) * 1989-02-04 1990-08-09 Basf Ag Verfahren zur herstellung von kondensierten cyclischen amidinen
JP3198117B2 (ja) * 1990-02-07 2001-08-13 サントリー株式会社 ピロロアゼピン誘導体

Also Published As

Publication number Publication date
KR100255131B1 (ko) 2000-04-15
EP0441349A1 (de) 1991-08-14
US5206239A (en) 1993-04-27
ES2084719T3 (es) 1996-05-16
DK0441349T3 (da) 1996-05-13
DE69115943D1 (de) 1996-02-15
CA2035749A1 (en) 1991-08-08
CA2035749C (en) 2001-10-23
JPH0597856A (ja) 1993-04-20
JP3198117B2 (ja) 2001-08-13
AU7080691A (en) 1991-08-08
EP0441349B1 (de) 1996-01-03
ATE132497T1 (de) 1996-01-15
AU642960B2 (en) 1993-11-04
US5391731A (en) 1995-02-21
US5416082A (en) 1995-05-16

Similar Documents

Publication Publication Date Title
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
DE69028136T2 (de) Alkoxyiminoacetamid-Derivate und ihre Verwendung als pilztötendes Mittel
CA2161542A1 (en) Novel 5-Pyrrolyl-2-Pyridylmethylsulfinyl Benzimidazole Derivatives
ES2164241T3 (es) Compuestos pentaciclicos.
DE69115943D1 (de) Pyrroloazepinderivate
PT86770A (pt) Process for preparing benzophenone derivatives
PT916651E (pt) DERIVADOS DE áCIDO FENILALQUILCARBOXILICO
HU9600621D0 (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
EP0555479A4 (de)
DE69631521D1 (de) Propenonderivate
DE69311999T2 (de) Verfahren zur Herstellung von Amino-Thiadiazolylacetylhaliden
ATE98635T1 (de) Sterisch gehinderte aminoverbindungen und verfahren zu deren herstellung.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.
DE69127396D1 (de) Verfahren zur Herstellung von Dihydrofuranonderivaten
HUT49845A (en) Process for producing optically active n-substituted alanine derivatives with herbicidal effect

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8339 Ceased/non-payment of the annual fee